Etomidate and Esketamine on Postoperative Pain After Tonsillectomy Undergoing Children

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-10
SponsorAnqing Municipal Hospital

About this trial

Objective: To explore the effect of etomidate and esketamine on postoperative pain after tonsillectomy in children.

Methods: Investigators enrolled 64 children with American Society of Anesthesiologists (ASA) physical status I and II, aged 2-10 years, and scheduled for elective undergoing tonsillectomy with general anesthesia. All the enrolled patients were randomly divided into etomidate and fentanyl group (Group A) and etomidate and esketamine group (Group B). In the etomidate-fentanyl group (group A), 0.3 mg/kg etomidate and 4 µg/kg fentanyl were given at the induction of anesthesia, followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the surgery, respectively; in the etomidate-esketamine group (group B), induction of anesthesia with 0.3 mg/kg etomidate and 0.5 mg/kg esketamine , followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the operation. Anesthesiologists who were unaware of the grouping recorded the FlACC Pain Scale at 2 h, 8 h, and 24 h after surgery.

Eligibility criteria

Qualifiers

Children who underwent elective tonsillectomy

Aged 2-10 years old

ASA class I-II

Disqualifiers

Children with hepatic or renal dysfunction

Those with increased intracranial or intra-ocular pressure

Children with schizophrenia, bipolar disorder, and any other psychiatric condition

Children with preexisting chronic pain

Trial design

Treatments tested in this trial

  • Etomidate and fentanyl group
  • Etomidate and esketamine group

Treatment groups

64 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators